Medical Condition News

RSS

Iced tea increases risk of kidney stone formation and surgery

Unfortunately, for health reasons, Mulac has been forced to go cold turkey. All the iced tea he was downing helped to bring on an excruciating bout of kidney stones that eventually led to surgery at Loyola University Hospital in Maywood, Ill.

21 Jul 2010

California companies are developing new medicines for diabetes: Report

Pharmaceutical research and biotechnology companies based in California are researching and developing 58 new medicines for diabetes, a chronic disease that afflicts 220 million patients worldwide, including 23.6 million Americans, a new report shows.

21 Jul 2010

iCAD launches new advanced MRI product suite

iCAD, Inc., an industry-leading provider of advanced image analysis and workflow solutions for the early detection of cancer, today announced the launch of an MRI product suite for breast, prostate, and other organs. The product suite, which is a comprehensive quantitative image analysis solution, brings together the company's current products SpectraLook® and VividLook® with the new OmniLook™ and VersaVue™ Enterprise, to offer a comprehensive quantitative image analysis suite.

21 Jul 2010

DermaGenoma announces availability of PsoriasisDX Genetic Test as CE Marked product for PsA

Molecular dermatology research and development innovator DermaGenoma, Inc. today announced that the PsoriasisDX Genetic Test for Psoriatic Arthritis is now available as a CE Marked product under the European In Vitro Diagnostic Directive.

21 Jul 2010

Vanderbilt University Medical Center performs specialized PET/CT scan to locate cancerous tumors

Vanderbilt University Medical Center and affiliated VA Tennessee Valley Healthcare System are the first in the U.S. to perform a specialized PET/CT scan to successfully locate the presence of tumors.

21 Jul 2010

Depressive symptoms in patients with HCV infection overlooked

Researchers from Denmark, Sweden, Norway and Finland (the NORDynamIC project group) have observed that depressive symptoms in patients with hepatitis C virus (HCV) infection are commonly overlooked in routine clinical interviews, and that treatment-induced depression compromises the outcome of HCV therapy. A second U.S. study found that patients with chronic infection had lower (work) productivity and incurred higher medical benefit costs than those without HCV.

21 Jul 2010

Scientists identify key genes for Silk Road disease

Scientists have identified key genes responsible for a severe inflammatory disease that has spread along the old silk trading routes from the Far East to the edge of Europe.University of Manchester researchers, working as part of a large international consortium, have revealed some of the genetic mutations that lead to Behçet's disease. The group's findings are published in Nature Genetics.

21 Jul 2010

La Jolla Institute forms partnership to investigate potential new therapy for sickle cell disease

Researchers from the La Jolla Institute for Allergy & Immunology have joined forces with the Dana-Farber Cancer Institute in Boston and Washington University in St. Louis to investigate a potential new therapy for sickle cell disease, a severe and chronic illness affecting more than 70,000 Americans and several million people worldwide.

21 Jul 2010

Study demonstrates direct link between juvenile compensatory growth and reproduction

University of California, Riverside biologists working on guppies - small freshwater fish that have been the subject of long-term studies - report that rapid growth responses to increased food availability after a period of growth restriction early in life have repercussions in adulthood.

21 Jul 2010

Mesoblast gains Australian TGA licence to manufacture Mesenchymal Precursor Cell products

Australian regenerative medicine company, Mesoblast Limited, today announced that the Australian Therapeutic Goods Administration (TGA) has issued a licence to Mesoblast to manufacture and supply its proprietary Mesenchymal Precursor Cell (MPC) products.

21 Jul 2010

Living with children has a negative influence on parents' ability to exercise: Study

A study conducted at the Montreal Heart Institute has shown unexpectedly that living with children is linked to a reduction in physical activity. Carried out with 756 participants and led by Dr. Simon L. Bacon, Associate Researcher at the MHI and Professor at Concordia University, the study assessed the impact of social networks on exercise, revealing that people with heart disease who live with children exercise less than those people who do not live with children.

21 Jul 2010

Explicit differences exist between meditation techniques

As doctors increasingly prescribe meditation to patients for stress-related disorders, scientists are gaining a better understanding of how different techniques from Buddhist, Chinese, and Vedic traditions produce different results.

21 Jul 2010

Lannett's ANDA for Phentermine Hydrochloride Blue/White Seed Capsules receives FDA approval

Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Phentermine Hydrochloride Blue/White Seed Capsules USP, 30 mg, the generic equivalent of Sandoz, Inc.'s Reference Listed Drug (RLD) Phentermine Hydrochloride Capsules USP, 30 mg.

21 Jul 2010

Lifestyle changes can prevent arthritis, knee replacement

Taking a few small steps toward protecting your knees when you are younger might help you avoid debilitating problems when you get older.

21 Jul 2010

Mental exercises may help reverse age-related cognitive decline

Specialized brain training targeted at the regions of a rat's brain that process sound reversed many aspects of normal, age-related cognitive decline and improved the health of the brain cells, according to a new study from researchers at University of California, San Francisco.

21 Jul 2010

Over-expression of Arpc1b promotes tumorigenic properties of breast cancer cells: Research

A major discovery, led by researchers from The George Washington University Medical Center, promises to revolutionize the way scientists think about key aspects of cellular lifecycle and offers a new avenue for cancer researchers to explore in their quest to one day slow down the progression of cancer.

21 Jul 2010

Hybrid Linac-MR imaging system tracks cancer tumors in real time

Today, at the 52nd Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia, a group of researchers from Stanford University will describe the latest developments toward their goal of integrating two existing medical devices -- medical linear accelerators, or "linacs," which produce powerful X-rays for treating cancer, and magnetic resonance imagers (MRIs), which are widely used to image tumors in the human body.

21 Jul 2010

Men with asthma or eczema at lower risk of developing cancer

Men who had a history of asthma or eczema generally had a lower risk of developing cancer, according to a study carried out by researchers at INRS-Institut Armand-Frappier, the Research Centre of the Centre hospitalier de l'Université de Montréal, and McGill University. The findings, published in the Annals of Allergy, Asthma & Immunology, show that male eczema sufferers had a lower risk of lung cancer while those with a history of asthma had a similar effect in relation to stomach cancer.

21 Jul 2010

GCSF administration can reduce side effects of cancer neurobastoma in children

Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.

21 Jul 2010

FDA accepts MannKind's resubmission of AFREZZA NDA, sets PDUFA action date

MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.

21 Jul 2010

Medical Condition News

Iced tea increases risk of kidney stone formation and surgery

California companies are developing new medicines for diabetes: Report

iCAD launches new advanced MRI product suite

DermaGenoma announces availability of PsoriasisDX Genetic Test as CE Marked product for PsA

Vanderbilt University Medical Center performs specialized PET/CT scan to locate cancerous tumors

Depressive symptoms in patients with HCV infection overlooked

Scientists identify key genes for Silk Road disease

La Jolla Institute forms partnership to investigate potential new therapy for sickle cell disease

Study demonstrates direct link between juvenile compensatory growth and reproduction

Mesoblast gains Australian TGA licence to manufacture Mesenchymal Precursor Cell products

Living with children has a negative influence on parents' ability to exercise: Study

Explicit differences exist between meditation techniques

Lannett's ANDA for Phentermine Hydrochloride Blue/White Seed Capsules receives FDA approval

Lifestyle changes can prevent arthritis, knee replacement

Mental exercises may help reverse age-related cognitive decline

Over-expression of Arpc1b promotes tumorigenic properties of breast cancer cells: Research

Hybrid Linac-MR imaging system tracks cancer tumors in real time

Men with asthma or eczema at lower risk of developing cancer

GCSF administration can reduce side effects of cancer neurobastoma in children

FDA accepts MannKind's resubmission of AFREZZA NDA, sets PDUFA action date

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News